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Introduction. Critically ill patients, including obstetrical patients, face undernutrition but a 
reliable and cost effective study to assess their nutritional state is still missing. Our main objective 
was to analyze serum leptin and adiponectin concentrations in puerperal women attended in an 
Obstetrical Intensive Care Unit (OICU) in order to evaluate their potential role as nutritional metabolic 
parameter.  
Methods. This was a descriptive, clinical, longitudinal and comparative study. We evaluated 
the anthropometric variables, clinical laboratories, daily calories and adiponectin and leptin serum 
levels of 16 puerperal women attended at the OICU of the Materno Perinatal Hospital “Mónica 
Pretelini” (HMPMP).  
Results. For all women there was a negative correlation with Spearman test between leptin the 
day of discharge from the obstetrical intensive care unit and the days of stay –0.632 (p = 0.011). 
Considering an adiponectin/leptin ratio, the media in the first day was of 0.3 (0.07–13.6) and in the 
day of discharge it was of 2.4 (0.1–24.6) in overweight women. The same values for obese women 
were of 0.3 (0.2–0.4) and 0.5 (0.3–1.2). 
Conclusion. After an average of six days of hospitalization, leptin showed a decrement in 
women attended at the OICU. As expected, adiponectin increased in both groups. The adiponectin/ 
leptin ratio could be a useful metabolic parameter.  
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Critically ill patients, especially those with 
sepsis or septic shock, even without pre-existing 
diabetes mellitus face three common metabolic 
features: hyperglycemia, glucose intolerance, and 
insulin resistance [1–3]. Several adipocytokines 
that mediate agonistic and antagonistic effects on 
insulin resistance have been identified in patients 
with obesity, metabolic syndrome, and type 2 
diabetes [4, 5]. These hormones are a link among 
obesity, inflammation and systemic insulin resistance 
[5]. In this regard, pregnancy is a physiological 
state of overweight, obesity and insulin resistance. 
Adiponectin, a product of the apM1 gene, is 
highly expressed in adipose cells, and circulates in 
high concentrations in the blood with crucial 
importance in regulating insulin sensitivity. It has a 
globular domain and a collagen domain. Decreased 
serum levels of adiponectin are associated with 
insulin resistance. 
The role of adiponectin in systemic 
inflammation and critical illness is not well 
defined. For example, low levels of adiponectin 
have been found in critically ill patients, although 
data is limited in human subjects at this stage. The 
variability in the serum adiponectin levels is partly 
attributed to various options for modulation of this 
hormone [6]. 
Pregnancy has an enhancing effect on the 
relationship between body fatness and insulin 
resistance [7]. According to the available information 
it is clear that plasma adiponectin levels are 
decreased in women who are in the last trimester of 
gestation.  
Leptin, a 16-Kd protein encoded by the Ob 
gene, correlates directly with the mass of adipose 
tissue and its main function is to control the appetite. 
Leptin exerts its various actions on glucose 
metabolism and energy expenditure via binding to 
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the leptin-receptor in the brain and peripheral 
tissues as liver, pancreas, adipose tissue and in the 
immune system [8]. Several animal and human 
studies have shown that administration of endotoxin, 
tumour necrosis factor alpha (TNF-α) and other 
cytokines which act as inducers of severe systemic 
inflammation result in a significant elevation of 
serum leptin concentrations [9, 10].  
Obese patients hospitalized in Intensive Care 
Units (ICUs) have increased mortality compared 
with non-obese. Both adiponectin and leptin have 
been found intertwined in studies examining the 
complex set of biochemical-metabolic reactions 
associated with the level of obesity, the degree of 
complications and prognosis in patients treated in 
ICUs. Thus, adiponectin and leptin levels may act 
as prognostic markers. 
Christos et al., found in an observational 
study in adults a positive correlation between a diet 
rich in protein and serum leptin levels decrement. It 
has also been reported by Steiner et al., a direct 
relationship between the level of leptin, the protein 
intake in diet and the level of obesity in mouse 
models [5]. 
Taken in the context of the implication of 
adipocytokines and prognosis in critically ill 
patients, maintaining a normal glycaemia level has 
beneficial effects on outcome. Besides insulin, 
plasma glucose concentrations may be lowered by 
hypocaloric feeding, or by the type of formula used 
[11]. Whether such type of diets influences the 
results of serum levels of adiponectin or leptin is a 
matter of debate.  
A reliable and cost-effective study to assess 
the nutritional state in obstetrical patients has yet to 
be designed. Our main objective was to analyze 
serum leptin and adiponectin concentrations in a 
cohort of puerperal women attended in an 
Obstetrical Intensive Care Unit (OICU) in order to 
evaluate their potential role as nutritional metabolic 
parameters. 
MATERIAL AND METHODS 
Study design and patient characteristics 
This was a descriptive, clinical, longitudinal 
and comparative study. We enrolled consecutively 
16 women in immediate puerperium upon admission 
to the medical OICU of the Materno Perinatal 
Hospital “Mónica Pretelini” (HMPMP) from 
February till March 2011. 
Patients were not included in this study if 
they were expected to have a short-term (<24 h) 
intensive care hospitalization or if they suffered 
from gestational diabetes mellitus. Patient data, 
clinical information, and blood samples were 
collected prospectively. 
The patients were classified in two groups by 
Body Mass Index (BMI): a) overweight (24.9 k/m2 < 
BMI < 29.9 k/m2) and b) obesity (BMI > 29.9 k/m2) 
that did not differ in APACHE II score, vasopressor 
demand, or laboratory parameters. For reference of 
a normal value we processed samples of a normal 
weight puerperal woman. 
Anthropometric measures 
Height with a measuring tape and weight 
with an electric bed (Hill-Rom, Total Care) were 
uniformly recorded at the OICU. Corrected final 
weight (CFW) was calculated (if it was positive) 
as: final weight (kg)-accumulated hydric balance 
(L/1000). Blood pressure was measured with an 
electronic monitor (Infinity Delta XL, Dräger). 
Laboratory 
After delivery and during each day of 
hospitalization, with a fasting period of eight hours 
blood samples were collected into Vacutainer tubes 
and centrifuged to separate serum from plasma. We 
measured albumin (mg/dL), cholesterol (mg/dL), 
creatinine (mg/dL), glucose (mg/dL), triglycerides 
(mg/dL) and uric acid (mg/dL) (Dimension R × L 
Max, Dade Behring) and haemoglobin (g/dL) (Advia 
120, Bayer Health). All these tests were measured 
in the HMPMP according to standardized procedures 
recommended by the International Federation of 
Clinical Chemistry and Laboratory Medicine (IFCC). 
Very low-density lipoproteins (VLDL) were cal-
culated as triglycerides (mg/dL)/5. 
Quantification of adiponectin and leptin  
Adiponectin and leptin serum concentrations 
were measured at the Medical Research Center 
(CICMED), Autonomous University of the State of 
Mexico (UAEMex), using an enzyme-linked immuno-
sorbent assay (ELISA) according to manufacturer’s 
instructions (GenWay Biotech. Inc; High sensibility 
ELISA Sandwich Adiponectin reference 40-055-
200002 and Human Leptin ELISA Sandwich reference 
40-055-200004).  
The present study was approved by the 
Ethical Committee of the HMPMP (Code: 2010-
08-124) and was conducted in accordance with the 
ethical standards laid down in the 1964 Declaration 
of Helsinki. Written informed consent was obtained 
from the patient, her spouse, or the appointed legal 
guardian. 
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Statistical analysis 
Statistical analysis was done using the 
Statistical Package for Social Science (SPSS) 
software, version 17 (SPSS Inc., Chicago, United 
States). Box plot graphics were used to illustrate 
comparisons between groups. Due to the skewed 
distribution of most of the parameters, data are 
given as median (range). Differences between two 
groups were assessed by Mann-Whitney-U-test.  
RESULTS 
The principal diagnoses of the attended 
patients were: preeclampsia, obstetric haemorrhage, 
HELLP syndrome, renal dysfunction and pneu-
monia. 
Clinical data 
Anthropometric measures are shown in Table 
I. Of eleven women with overweight, 54.5% [6] 
lost weight during their hospitalization, 36.3% (4) 
gained weight and one (9%) stayed without 
changes. Of the three women with obesity, all lost 
weight. Taking into account all women, 60% [9] 
lost weight, 33.3% [5] gained weight and one 
(6.6%) kept the same weight. One woman with 
overweight reached normal BMI at the end of the 
study. A statistical significant difference was found 
in initial and final weight and BMI and in initial 
systolic blood pressure. Adjusting BMI to CFW 
gives eight (72.7%) of the overweight women that 
showed a reduction in this value. There was no 
difference when analyzing the mean kcal/kg/day 
consumed.
Table I 
Anthropometric and laboratorial characteristics 
 Overweight Obesity 
Age (years) 28 (18-42) 34 (29-36) 
Days of stay 6 (2-21) 5 (4-6) 
kcal/kg/day 14.9 (7.3-31.7) 20.5 (12.3-21.1) 
Weight (kg)a ** 63 (54.5-72.6) 92.6 (73.3-97.2) 
Weight (kg)b * 61 (51.8-77.6) 83.9 (66.6-94.3) 
Height (m) 1.54 (1.47-1.66) 1.56 (1.52-1.6) 
BMI (kg/m2)a ** 26.3 (25.2-28.5) 37.9 (31.7-38) 
BMI (kg/m2)b * 26.1 (22.8-30.9) 34.4 (33.3-36.8) 
Adiponectin (µg/mL)a 8.6 (2.9-26) 7.9 (4.1-12.8) 
Adiponectin (µg/mL)b 12.4 (5.1-22.9) 8 (3.6-9.5) 
Leptin (ng/mL)a 8.6 (1-55.9) 23.3 (16.5-25.9) 
Leptin (ng/mL)b 6.2 (0.7-33.3) 6.8 (6.4-27.3) 
Glucose (mg/mL)a 127 (84-226) 165 (68-231) 
Glucose (mg/mL)b 96 (75-194) 81 (73-157) 
BMI: Body Mass Index; a: initial; 
b: final. Results in media (range). 




Overweight and obese women decreased their 
BMI (Fig. 1) and leptin (Fig. 2) while hospitalized, 
at the same time adiponectin showed an expected 
increase in both groups (Fig. 3). There were no 
differences in the studies realized, but glucose 
diminished in both groups. For all women there 
was a negative correlation with Spearman test 
between leptin the day of discharge from OICU 
and the days of stay –0.632 (p = 0.011). 
Considering an adiponectin/leptin ratio, the 
media in the first day was of 0.3 (0.07–13.6) and in 
the day of discharge it was of 2.4 (0.1–24.6) in 
overweight women. The same values for obese 
women were of 0.3 (0.2–0.4) and 0.5 (0.3–1.2). 
The mean in the adiponectin/leptin ratio in 
the first day of hospitalization was 7.9 fold higher 
in overweight than in obese women. In the last day 
of hospitalization this ratio was reduced to 6.1 fold. 
Intragroup modifications were also documented, as 
the previous ratio was 3.7 fold higher after ICU 
discharge in overweight women in comparison to 
the first day of hospitalization and 2.4 fold higher 
for obese women. 




Fig. 1. Body mass index in obstetrical intensive care patients. 
 
Fig. 2. Serum leptin concentrations in obstetrical intensive care patients.  
LEPTIN1: serum leptin in the first day of hospitalization, LEPTIN2: serum leptin in the last day of hospitalization. 
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Fig. 3. Serum adiponectin concentrations in obstetrical intensive care patients.  
ADIPO1: serum adiponectin in the first day of hospitalization, ADIPO2: serum adiponectin in the last day of hospitalization. 
DISCUSSION 
Overweight and obesity are frequent challenges 
in ICUs; previous research reported that about 50% 
of the patients admitted to an ICU have a BMI 
above 25 kg/m2. In our unit, of 15 puerperal 
women incorporated in the study only one had BMI 
below 25. This is explained, in part, by the fact that 
gestation is a period of intense weight gain. Thus 
predisposing to metabolic problems not as common 
in other kind of ICUs. 
A reliable assessment of nutritional state in 
obstetrical patients is of great importance to follow 
an evidence-based nutritional management protocol. 
Nevertheless, techniques used to assess body 
composition in this kind of patients may be 
affected by abnormalities in fluid status [12, 13] or 
are not practical as every day techniques for 
nutritional evaluation [14]. Research concerning 
the relationship between adiponectin and insulin 
action in humans is more complex than often 
suggested [15]. Adiponectin has significant anti-
inflammatory and insulin-sensitizing effects and is 
diminished in morbidly obese and in critically ill 
patients. Reduced adiponectin could contribute to 
insulin resistance in these patients. Serum adipo-
nectin upon admission to the intensive care unit 
may predict mortality in critically ill patients.  
Although adiponectin serum concentration 
does not differ between healthy controls and 
critically ill patients, neither in patients with nor in 
patients without sepsis, low adiponectin levels at 
admission to ICU have been identified as an 
independent predictor of survival [16]. Leptin has 
been implicated to link inflammation and metabolic 
alterations by using the same clinical approach.  
In women with normal cortisol levels, 
irrespectively of nutritional status, leptin levels 
reflect body fat content. In obese subjects, leptin 
levels may be influenced by cortisol levels, high 
levels of insulin, insulin growing factor-1 (IGF-1), 
and beta-endorphin as well as low levels of growth 
hormone [17]. Besides, leptin’s concentrations 
directly reflect the current nutritional status in non-
critically ill individuals. Moreover, it had been 
reported that circulating leptin levels are low in 
critically ill patients upon admission to the ICU, 
possibly due to an acute stress response, with the 
lowest levels in patients with sepsis [18].  
Serum leptin is closely associated with 
obesity and diabetes, has a functional role in the 
pathogenesis of severe illness [19] and clearly 
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correlates with markers of metabolism and liver 
function. In fact, a prior study demonstrated 
decreased plasma leptin levels due to trauma which 
were explained to be partly related to the initial 
fasting conditions because of refeeding elevated 
serum leptin concentrations to normal levels [20]. 
We, therefore, tested leptin serum concentrations in 
critically ill obstetric patients, finding higher leptin 
levels in patients with a BMI greater than 30 kg/m2.  
Patients in ICUs are submitted to energy 
restriction that causes a fall of serum leptin 
apparently not mediated by gastrointestinal signals 
and it seems not to affect the long-term regulatory 
pathways of circulating leptin [21]. There are many 
critical conditions that put critical patients in 
parenteral or tube feeding for periods of hours to 
days. In this respect, there is a rise in circulating 
leptin concentrations, associated with tube feeding 
[22]. In rats fed with standard chow or infusion of 
total parenteral nutrition into the duodenum or 
intravenously, leptin mRNA and serum concen-
trations were similar, but intravenous glucose 
infusion was mostly responsible for stimulation of 
the leptin gene and hormone secretion [23]. In our 
work it is not excluded the possibility that the type 
of diet (enteral, parenteral, mix) could affect the 
adipocytokines’ response in obstetrical patients but 
this topic was beyond the scope of this study due to 
the low number of patients. 
Our results of adiponectin and leptin were 
consistent with those reported by other researchers. 
We also noted that leptin correlated negatively with 
the days of hospitalization. In this sense, caloric 
portion of the different diets could be affecting the 
adipocytokines’ levels [2, 5]. However, in this study, 
there was no difference in the average kcal/kg/day 
provided in obese versus overweight women.  
The influence of fluid status on the body 
composition and nutritional evaluation has been 
tested by various techniques such as its relation to 
left ventricular end-diastolic diameter, assessed by 
echocardiography, and by estimating the ratio 
between extracellular water and total body water, 
assessed by bromide and deuterium dilution [12]. 
An important point of view derived from our work 
is that the total body weight is not a reliable data on 
hospitalized patients to calculate BMI because the 
water balance affects it, consequently, we used a 
CFW formula trying to avoid under-recording of 
weight loss.  
It is clear from this study that an adiponectin/ 
leptin ratio could be useful to evaluate the 
metabolic state in critical obstetric patients, due to 
the exclusive secretion of leptin by adipose tissue. 
Although we did not find a statistically significant 
difference in this ratio between obese and overweight 
women, the p value decreased 3.2 times (from 0.55 
to 0.17), which suggests that a longer period of 
hospitalization may lead to a difference in this 
ratio. It is likely that this difference could be more 
notorious when comparing to normal weight women. 
A limiting factor of this descriptive study is 
the small number of patients, but the trend in the 
response of the adipocytokines analyzed seems to 
reinforce the statement that the type of diet is not as 
critical as the BMI (corrected for water balance) to 
determine their serum levels. 
 
 
Introducere. Pentru pacienţii în stare critică, inclusiv pacienţii cu probleme 
obstetricale, subnutriţi, lipseşte un studiu de eficienţă fiabilă de a evalua starea lor 
nutriţională. Principalul nostru obiectiv a fost de a analiza concentraţiile serice de 
leptină şi adiponectină la femei cu endometrită, ce au participat într-o Unitate de 
Terapie Intensivă de Obstetrică (OICU), în scopul de a evalua rolul lor potenţial 
ca parametru metabolic nutriţional. 
Metode. Acesta a fost un studiu clinic descriptiv, longitudinal şi comparativ. 
Am evaluat variabilele antropometrice, clinice, de calorii pe zile şi nivelurile serice 
de adiponectină şi leptină la 16 femei cu endometrită ce au participat la OICU a 
Spitalului Materno Perinatal „Monica Pretelini” (HMPMP). 
Rezultate. Pentru toate femeile a existat o corelaţie negativă cu Spearman 
test între leptina în ziua externării din Unitatea de Terapie Intensivă de Obstretică 
şi de zilele de şedere –0,632 (p = 0,011). Având în vedere raportul adiponectină / 
leptinămedia în prima zi a fost 0,3 (0,07–13,6) şi în ziua de încheiere a fost de 2,4 
(0,1–24,6) la femeile supraponderale. Aceleaşi valori pentru persoane supra-
ponderale au fost 0,3 (0,2–0,4) şi 0,5 (0,3–1,2). 
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Concluzie. După o medie de şase zile de spitalizare, concentraţia de leptină a 
arătat o scădere la femeile ce au participat la OICU. Cum era de aşteptat, 
concentraţia de adiponectină a crescut în ambele grupuri. Raportul adiponectină/ 
leptină ar putea fi un parametru metabolic util. 
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